» Articles » PMID: 30199576

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6

Abstract

Long noncoding RNAs (lncRNAs) play a critical role in the regulation of many important cellular processes. However, the mechanisms by which lncRNAs regulate viral infection and host immune responses are not well understood. We sought to explore lncRNA regulation of hepatitis C virus (HCV) infection and interferon response. We performed RNA sequencing (RNAseq) in Huh7.5.1 cells with or without interferon alpha (IFNα) treatment. Clustered regularly interspaced short palindromic repeats/Cas9 guide RNA (gRNA) was used to knock out selected genes. The promoter clones were constructed, and the activity of related interferon-stimulated genes (ISGs) were detected by the secrete-pair dual luminescence assay. We constructed the full-length and four deletion mutants of an interferon-induced lncRNA RP11-288L9.4 (lncRNA-IFI6) based on predicted secondary structure. Selected gene mRNAs and their proteins, together with HCV infection, in Huh7.5.1 cells and primary human hepatocytes (PHHs) were monitored by quantitative real-time PCR (qRT-PCR) and western blot. We obtained 7,901 lncRNAs from RNAseq. A total of 1,062 host-encoded lncRNAs were significantly differentially regulated by IFNα treatment. We found that lncRNA-IFI6 gRNA significantly inhibited HCV infection compared with negative gRNA control. The expression of the antiviral ISG IFI6 was significantly increased following lncRNA-IFI6 gRNA editing compared with negative gRNA control in Japanese fulminant hepatitis 1 (JFH1)-infected Huh7.5.1 cells and PHHs. We observed that lncRNA-IFI6 regulation of HCV was independent of Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling. lncRNA-IFI6 negatively regulated IFI6 promoter function through histone modification. Overexpression of the truncated spatial domain or full-length lncRNA-IFI6 inhibited IFI6 expression and increased HCV replication. Conclusion: A lncRNA, lncRNA-IFI6, regulates antiviral innate immunity in the JFH1 HCV infection model. lncRNA-IFI6 regulates HCV infection independently of the JAK-STAT pathway. lncRNA-IFI6 exerts its regulatory function via promoter activation and histone modification of IFI6 through its spatial domain.

Citing Articles

The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.

Yuan H, Xu R, Li S, Zheng M, Tong Q, Xiang M MedComm (2020). 2025; 6(3):e70121.

PMID: 40060195 PMC: 11890166. DOI: 10.1002/mco2.70121.


IAV Antagonizes Host Innate Immunity by Weakening the LncRNA-LRIR2-Mediated Antiviral Functions.

Chen N, Zhang B Biology (Basel). 2025; 13(12.

PMID: 39765665 PMC: 11727275. DOI: 10.3390/biology13120998.


KMT2A regulates the autophagy-GATA4 axis through METTL3-mediated mA modification of ATG4a to promote NPCs senescence and IVDD progression.

Wu O, Jin Y, Zhang Z, Zhou H, Xu W, Chen L Bone Res. 2024; 12(1):67.

PMID: 39572532 PMC: 11582572. DOI: 10.1038/s41413-024-00373-1.


Machine learning-based analysis of Ebola virus' impact on gene expression in nonhuman primates.

Rezapour M, Niazi M, Lu H, Narayanan A, Gurcan M Front Artif Intell. 2024; 7:1405332.

PMID: 39282474 PMC: 11392916. DOI: 10.3389/frai.2024.1405332.


The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.

Zychowska J, Cmil M, Skorka P, Olejnik-Wojciechowska J, Plewa P, Bakinowska E Biomolecules. 2024; 14(8).

PMID: 39199374 PMC: 11352264. DOI: 10.3390/biom14080986.


References
1.
de Veer M, Holko M, Frevel M, Walker E, Der S, Paranjape J . Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001; 69(6):912-20. View

2.
Fried M, Shiffman M, Reddy K, Smith C, Marinos G, Goncales Jr F . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002; 347(13):975-82. DOI: 10.1056/NEJMoa020047. View

3.
Hadziyannis S, Sette Jr H, Morgan T, Balan V, Diago M, Marcellin P . Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004; 140(5):346-55. DOI: 10.7326/0003-4819-140-5-200403020-00010. View

4.
Lin W, Choe W, Hiasa Y, Kamegaya Y, Blackard J, Schmidt E . Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology. 2005; 128(4):1034-41. DOI: 10.1053/j.gastro.2005.02.006. View

5.
Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T . Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat. 2006; 13(10):690-700. DOI: 10.1111/j.1365-2893.2006.00732.x. View